Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Anemia × luspatercept × Clear all

Phase

Status

Completed 2 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1 Classical hematology 1

Conditions

Primary Myelofibrosis 1 Myeloproliferative Disorders 1 Anemia 1

Interventions

luspatercept 1 ibrutinib 1 fludarabine phosphate 1 Taxes 1 Rituximab 1 Pharmacogenomic Testing 1 Lenalidomide 1 Gemcitabine 1 Epoetin Alfa 1 Cyclophosphamide 1 CT-P10 1 Biopsy 1 Ascorbic Acid 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04717414 2025-07-10

INDEPENDENCE

Celgene

Phase 3 Active not recruiting

Classical hematologyMyeloid

Anemia, Myeloproliferative Disorders, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡